Latest COVID-19 variant-of-concern Omnicron found in 15 more countries
Category: #headlines  | By Nikita Chaurasia  | Date: 2021-11-29 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Latest COVID-19 variant-of-concern Omnicron found in 15 more countries

New COVID-19 variant Omnicron, which was initially found in South Africa, has now been detected in 15 more countries such as Denmark, the Netherlands, Switzerland, and Australia. These nations have also reverted to travel restrictions to curb the spread of the new variant.

The detection of Omicron has sparked worldwide panic, with governments scrambling to impose new travel restrictions and markets selling off, over fears that the variant would resist vaccinations and derail a fledgling economic recovery following a two-year global pandemic.

Even the World Health Organization (WHO) had recently announced Omnicron as a variant-of-concern, after studying the virus mutations that could have a significant impact on how it behaves or spreads. 

Experts believe that hospitalization rates in South Africa have been on the rise, but this could be due to an increase in the number of individuals infected rather than a specific infection.

Dr. Angelique Coetzee, chair of the South African Medical Association, mentioned that patients did not experience a loss of smell or taste or any significant decline in oxygen levels with the new variant.

Meanwhile, Israel stated it will restrict all foreigners from entering the country to keep Omnicron at bay. The ban, although subject to government approval, could last at least 14 days, said Prime Minister Naftali Bennett.

Meanwhile, the British government has announced measures such as stringent screening norms for newcomers and compulsory masks in certain conditions.

Other countries including Indonesia and Saudi Arabia have also placed new travel restrictions on Southern African countries. In this context, South Africa called these bans unjust and potentially destructive to its economy, claiming that the country is being penalized for its lack of scientific ability to detect the variant early.

The widespread outbreak of Omnicron has highlighted the discrepancies in immunization rates worldwide. According to a medical and human rights group, less than 7% of the population in underdeveloped countries have taken their first COVID-19 shot, while the wealthy countries are now considering a third booster dose.

Source Credit-

https://www.moneycontrol.com/news/world/omicron-variant-detected-in-more-countries-as-scientists-race-to-find-answers-7770871.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...

UK’s business confidence drops to its lowest point since 2009

UK’s business confidence drops to its lowest point since 2009

By Nikita Chaurasia

According to recent data, business confidence in the UK dropped to 18% in October, which was its lowest level in at least 13 years. In contrast, however, net balances of confidence stood at 28% in June and 56% in February, according to Accenture and ...

Attero aims to increase recycling capacity, plans for IPO in 2025

Attero aims to increase recycling capacity, plans for IPO in 2025

By Nikita Chaurasia

Attero Recycling, a firm that recycles electronic waste, is aiming to launch an initial public offering (IPO) in 2025, according to its Co-Founder and CEO Nitin Gupta. As per Gupta, the company is currently debating whether to list its shares in I...